PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRFX PRF Technologies Ltd.

Trading 06-16 13:10:39 EDT

1.73

-0.76

-30.52%

High1.79	Low1.50	Vol2.15M
Open1.66	D1 Closing2.49	Amplitude11.45%
Mkt Cap1.50M	Tradable Cap1.40M	Total Shares868.80K
T/O3.58M	T/O Rate265.45%	Tradable Shares808.80K
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PRFX","market":"US","secType":"STK","nameCN":"PRF Technologies Ltd.","latestPrice":1.73,"timestamp":1781629835334,"preClose":2.49,"halted":0,"volume":2146966,"delay":0,"changeRate":-0.3052208835341366,"floatShares":808800,"shares":868800,"eps":-7.469999,"marketStatus":"Trading","change":-0.76,"latestTime":"06-16 13:10:39 EDT","open":1.66,"high":1.79,"low":1.5049,"amount":3581992.706985,"amplitude":0.114498,"askPrice":1.74,"askSize":366,"bidPrice":1.71,"bidSize":282,"shortable":0,"etf":0,"ttmEps":-7.469999,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1781640000000},"marketStatusCode":2,"adr":0,"listingDate":1598932800000,"exchange":"NASDAQ","adjPreClose":2.49,"preHourTrading":{"tag":"盘前","latestPrice":1.67,"preClose":2.49,"latestTime":"09:29 EDT","volume":596769,"amount":1035805.7469023999,"timestamp":1781616599999,"change":-0.82,"changeRate":-0.329317,"amplitude":0.164659},"postHourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":2.49,"latestTime":"19:59 EDT","volume":6574732,"amount":14447237.2082,"timestamp":1781567998916,"change":-0.63,"changeRate":-0.253012,"amplitude":0.514056},"volumeRatio":0.391949},"requestUrl":"/m/hq/s/PRFX/tweets","defaultTab":"tweets","newsList":[{"id":"2643751757","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2643751757","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643751757?lang=en_us&edition=fundamental","pubTime":"2026-06-16 19:33","pubTimestamp":1781609589,"startTime":"0","endTime":"0","summary":"PRF Technologies  shares were down 27% in Tuesday premarket activity, following the previous session's 83% gain.Cuprina  stock was down 25% after a 111% gain in Monday's session.J-Star  shares were down 25% after the company said late Monday it received a Nasdaq delisting determination notice.Wearable Devices  stock was down 20%, following the previous session's 26% gain.Tianci International  shares were down 19%, extending the previous session's nearly 16% decline.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PRFX","CIIT","BK4007","YMAT","BK4198","BK4170","WLDS","BK4021","BK4190","CUPR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643882327","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:51 PM","url":"https://stock-news.laohu8.com/highlight/detail?id=2643882327","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643882327?lang=en_us&edition=fundamental","pubTime":"2026-06-16 02:51","pubTimestamp":1781549483,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 02:51 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260615:nAQN2M3KWE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639198841","title":"Consumer Tech News (May 25-29): Dell, IBM, CrowdStrike, Meta Lead Big Tech AI Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2639198841","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639198841?lang=en_us&edition=fundamental","pubTime":"2026-05-31 21:53","pubTimestamp":1780235604,"startTime":"0","endTime":"0","summary":"Dell beats massive estimates, IBM launches $5B Project Lightwell, CrowdStrike expands cyber insurance AI efforts, and Meta adds paid AI subscriptions across platforms.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/tech/26/05/52894213/consumer-tech-news-may-25-29-dell-ibm-crowdstrike-meta-lead-big-tech-ai-push","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GM","META","IREN","MDB","MSFX","SMCI","INFY","WB","KC","MRVL","AGIX","YMAG","ADSK","TSLA","ARTY","SOCL","PATH","CHAT","CRWV","RKLB","MSFT","VGT",".IXIC","SPCE","BULZ","TEM","CRM","PRFX","OKTA","DBB","CRWL","DELL","PLAB","HPQ","INTC","QCOM","EVS.SI","SNPS","NBIS","AI","CRWD","IBM","S","AIPO","XPEV","LI","TSM","MAGY","NVDA","HOOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639678857","title":"Why Is Penny Stock PRF Technologies (PRFX) Up Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2639678857","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639678857?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:19","pubTimestamp":1780060775,"startTime":"0","endTime":"0","summary":"PRF Technologies stock was up alongside an update on its renewable energy AI platform.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-prf-technologies-prfx-up-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-prf-technologies-prfx-up-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4007","PRF","PRFX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639245296","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639245296","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639245296?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:16","pubTimestamp":1780053401,"startTime":"0","endTime":"0","summary":"PRF Technologies  shares were up over 250% in Friday premarket activity after the company updated investors on the development of its DeepSolar Predict renewable energy revenue optimization platform ahead of a planned commercial launch.Sunlands Technology Group  stock was 123% higher after the company said its board authorized a plan to buy back up to $50 million of its Class A ordinary shares in the form of American depositary shares over the next 36 months.HUB Cyber Security  shares were up 52% after an investor filed an amended disclosure with the US Securities and Exchange Commission, showing a 15.6% beneficial ownership stake in the company.Nexera Technologies  stock was 47% higher, adding to a 5% rise in the Thursday session.Olenox Industries  shares were up 46% after the company said it closed the acquisition of CS Digital Ventures.QTREX Quantum  stock was 36% higher following the previous session's 42% increase.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4129","BK7064","BK4134","QTEX","BK4082","STG.AU","HUBC","BK4220","OLOX","PRFX","BK4506","BK4007","NEXR","BK4204","STG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638545511","title":"PRF Technologies announces results from study comparing PRF-110 to Zynrelef","url":"https://stock-news.laohu8.com/highlight/detail?id=2638545511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638545511?lang=en_us&edition=fundamental","pubTime":"2026-05-26 22:53","pubTimestamp":1779807182,"startTime":"0","endTime":"0","summary":"PRF Technologies (PRFX) announced positive results from a preclinical study in domestic pigs directly comparing its lead product candidate, PRF-110...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-results-from-study-comparing-prf-110-to-zynrelef-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-results-from-study-comparing-prf-110-to-zynrelef-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRF","BK4007","BK4588","PRFX","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638128195","title":"PRF Technologies says PRF-110 matches Zynrelef in 72-hour pig post-surgery pain study","url":"https://stock-news.laohu8.com/highlight/detail?id=2638128195","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638128195?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:31","pubTimestamp":1779798697,"startTime":"0","endTime":"0","summary":"PRF Technologies reported positive head-to-head preclinical results for PRF-110, its extended-release ropivacaine formulation for post-surgical pain.Results were presented in the announcement, not flagged for a future scientific meeting.PRF-110 delivered sustained pain relief over 72 hours comparable to ZYNRELEF in a pig incisional pain model.The outcome supported PRF-110’s single-dose, NSAID-free profile, positioning it as a potential non-opioid alternative for wound-bed administration.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDL6kjx0Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2W23.USD","LU0314104364.USD","IE00BN0W2V16.EUR","IE00BKPKM429.USD","LU2210150020.SGD","IE00B64PRP62.GBP","BK4112","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","NDAQ","LU2210149790.SGD","IE00BN0W2T93.GBP","PRFX","LU2095319765.USD","SG9999014013.SGD","SG9999014039.USD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638514076","title":"Prf Technologies Announces Prf-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2638514076","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638514076?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:30","pubTimestamp":1779798602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA4HMH8H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638512838","title":"Prf Technologies Ltd - Prf-110 Achieves Sustained Analgesia With Ropivacaine-Only, Nsaid-Free Formulation","url":"https://stock-news.laohu8.com/highlight/detail?id=2638512838","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638512838?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:30","pubTimestamp":1779798602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA4HMH8H:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638451288","title":"Prf Technologies Ltd - Prf-110 Shows Consistent Safety and Tolerability in Preclinical Pig Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2638451288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638451288?lang=en_us&edition=fundamental","pubTime":"2026-05-26 20:30","pubTimestamp":1779798602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nTUA4HMH8H:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633033431","title":"PRF Technologies sells 24,384 unregistered shares to Yorkville for fees","url":"https://stock-news.laohu8.com/highlight/detail?id=2633033431","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633033431?lang=en_us&edition=fundamental","pubTime":"2026-05-08 06:10","pubTimestamp":1778191839,"startTime":"0","endTime":"0","summary":"PRF Technologies entered standby equity purchase agreement with Yorkville that allows sales of up to USD 10 million of ordinary shares over 36 months in an unregistered offering under Section 4 and Rule 506 of Regulation D.Advance shares would be sold at 97% of lowest of three daily VWAPs over a three-trading-day pricing period, with option to set a minimum price.Upfront equity fees issued on signing included 12,192 ordinary shares as first installment of 1% commitment fee, another 12,192 ordinary shares for a USD 25,000 structuring fee.Future advances require SEC registration statement covering commitment, structuring, and advance shares to be declared effective.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PRF Technologies Ltd. pub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260507:nNDL6tR973:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630300371","title":"PRF Technologies announces FDA clearance of OcuRing-K NDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2630300371","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630300371?lang=en_us&edition=fundamental","pubTime":"2026-04-28 21:13","pubTimestamp":1777382015,"startTime":"0","endTime":"0","summary":"PRF Technologies (PRFX) announced that the FDA has cleared the company’s investigational new drug application for OcuRing-K, enabling the initiatio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-fda-clearance-of-ocuring-k-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/prf-technologies-announces-fda-clearance-of-ocuring-k-nda-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","PRFX","BK4585","LABU","BK4007","PRF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630301770","title":"PRF wins FDA IND clearance for OcuRing-K Phase II cataract trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630301770","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630301770?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:15","pubTimestamp":1777378541,"startTime":"0","endTime":"0","summary":"PRF Technologies received FDA clearance for IND application for OcuRing-K, enabling Phase II trial in cataract surgery patients.Multi-center US study start-up underway, with enrollment expected to begin in H2 2026.OcuRing-K is sustained-release intraocular ring delivering ketorolac via single intraoperative application.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nNDL5n3lSg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014021.USD","IE00BKPKM429.USD","BK4007","BK4588","LU2210149790.SGD","NDAQ","SG9999014039.USD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014013.SGD","IE00BGHQF748.EUR","PRFX","LU2210150020.SGD","SG9999014005.SGD","IE00B3QW5Z07.USD","BK4112","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630309729","title":"Prf Technologies Ltd - to Initiate Phase Ii Trial in U.S. With Enrollment Expected in H2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2630309729","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630309729?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:00","pubTimestamp":1777377606,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA55N0XD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630097283","title":"Prf Technologies Announces FDA Clearance of Ind Application for Ocuring™-K Phase Ii Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2630097283","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630097283?lang=en_us&edition=fundamental","pubTime":"2026-04-28 20:00","pubTimestamp":1777377606,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260428:nTUA55N0XD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625951259","title":"What's Going On With Pharma Company PRF Technologies On Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2625951259","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625951259?lang=en_us&edition=fundamental","pubTime":"2026-04-07 23:02","pubTimestamp":1775574132,"startTime":"0","endTime":"0","summary":"PRF Technologies outlines 2025 progress, with OcuRing-K ocular drug-delivery advancement and AI solar analytics growth.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/small-cap/26/04/51682881/whats-going-on-with-pharma-company-prf-technologies-on-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4217","BK4007","BK4585","PRF","SMA","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625467666","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2625467666","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625467666?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:17","pubTimestamp":1775474273,"startTime":"0","endTime":"0","summary":"PRF Technologies  shares were 40% higher pre-bell Monday following a largely muted previous session.Soleno Therapeutics  stock was up 39% after the company agreed to be acquired by Neurocrine Biosciences  in a $2.9 billion deal.Gilat Satellite Networks  shares were 4.4% higher, adding to gains from the previous session.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4020","PRFX","LU0109394709.USD","LU2065171311.SGD","LU2065171402.SGD","LU2065169927.USD","NBIX","LU0154245673.USD","IE00B19Z4B17.USD","GILT","IE0031619046.USD","BK4007","LU0889565916.HKD","LU0320765992.SGD","LU0154245756.USD","SLNO","LU2324357040.USD","LU2065170008.USD","LU0823416689.USD","IE00B7SZL793.SGD","IE00B66KJ199.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622826067","title":"Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2622826067","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622826067?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:09","pubTimestamp":1774613359,"startTime":"0","endTime":"0","summary":"Israeli drug delivery firm PainReform's 2025 net loss narrows on reduced R&D expensesOverviewIsrael healthcare and energy tech firm's 2025 net loss narrowed sharply from prior yearCompany completed De","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nL1N40F0DY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622782826","title":"PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2622782826","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622782826?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:05","pubTimestamp":1774613123,"startTime":"0","endTime":"0","summary":"LayerBio&#39;s OcuRing™-K program and broader ocular platform strengthen PRF&#39;s healthcare growth strategyDeepSolar advances from acquisition to early commercial deployment","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/03/51504675/prf-technologies-in-fy25-had-4-1m-in-cash-cash-equivalents-short-term-deposits-and-restricted-cash-","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","VHT","IXJ","BK4550","PRF","BK4588","BK4007","PRFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622982697","title":"Prf Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms","url":"https://stock-news.laohu8.com/highlight/detail?id=2622982697","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622982697?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:00","pubTimestamp":1774612801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nTUA8JV2VS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRFX","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prf-tech.com","stockEarnings":[{"period":"1week","weight":0.7055},{"period":"1month","weight":0.5759},{"period":"3month","weight":0.0289},{"period":"6month","weight":-0.4762},{"period":"1year","weight":-0.7323},{"period":"ytd","weight":-0.2241}],"compareEarnings":[{"period":"1week","weight":0.0211},{"period":"1month","weight":0.0212},{"period":"3month","weight":0.1253},{"period":"6month","weight":0.1243},{"period":"1year","weight":0.2644},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.0371},{"month":2,"riseRate":0.5,"avgChangeRate":0.071344},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.110271},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.187964},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.026301},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.0935},{"month":7,"riseRate":0.4,"avgChangeRate":-0.022654},{"month":8,"riseRate":0.4,"avgChangeRate":-0.15911},{"month":9,"riseRate":0.2,"avgChangeRate":-0.17317},{"month":10,"riseRate":0,"avgChangeRate":-0.160968},{"month":11,"riseRate":0.5,"avgChangeRate":-0.020834},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.071991}],"exchange":"NASDAQ","name":"PRF Technologies Ltd.","nameEN":"PRF Technologies Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"PRF Technologies Ltd.,PRFX,PRF Technologies Ltd.股票,PRF Technologies Ltd.股票老虎,PRF Technologies Ltd.股票老虎国际,PRF Technologies Ltd.行情,PRF Technologies Ltd.股票行情,PRF Technologies Ltd.股价,PRF Technologies Ltd.股市,PRF Technologies Ltd.股票价格,PRF Technologies Ltd.股票交易,PRF Technologies Ltd.股票购买,PRF Technologies Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PRF Technologies Ltd.(PRFX),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest PRF Technologies Ltd.(PRFX) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction